Celtic Therapeutics, now rebranded as Auven Therapeutics, is a private equity firm focused on innovative life science investments. Founded in 2007 by Stephen Evans-Freke and Dr. Peter B. Corr, the firm operates as a drug development company, managing Auven Therapeutics Holdings L.P. The company aims to provide the gold standard in drug development by acquiring controlling ownership in promising healthcare ventures.
Focus Areas
Notable Investments
